why choose us

First received: January 30, 2024

Clinical Trial: A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Influenza, Human

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA COVID-19 Vaccine and a Recombinant Influenza Vaccine Administered as a Single Injection in

Brief Summary: The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a single shot is safe and can help produce antibodies to defend the body against both SARS-CoV-2 (the virus that causes COVID-19) and influenza.Participants enrolled in this trial will be healthy adults, 50 years of age or older.

Read more